Alice Limkakeng

Alice Limkakeng has extensive work experience in various roles and industries. Alice currently serves as a Board Director for Breastcancer.org and Wellthy. Prior to that, they were the Chief Executive Officer of SleepArchitects and Vanguard Dental Partners.

Alice also worked as a Strategy Advisor and Investor at RiverVista Ventures, advising healthcare companies including HealthPlanOne, Patients Like Me, Boston Heart Diagnostics, and Breastcancer.org.

Alice held the position of Chief Business Officer and Board Member at Boston Heart Diagnostics, where they played a significant role in strategy development, product development, marketing, and corporate communications.

Alice had experience in venture capital as a Principal at Bain Capital Ventures, where they led and managed investments in the healthcare industry. Alice also worked as a Consultant at Mount Sinai School of Medicine.

Earlier in their career, Alice held management positions at Boston Scientific, where they successfully led the commercialization of a novel product and built a sales team for remote monitoring implantable cardio defibrillators. Alice was also a Regional Manager responsible for selling medical devices and driving adoption of new products.

Alice began their career as a Senior Associate at Behrman Capital, where they executed growth equity investments and worked closely with management on strategy and finances.

Overall, Alice Limkakeng has demonstrated strong leadership skills and a diverse range of experience in healthcare, venture capital, and strategy advisory roles.

Alice Limkakeng attended the Harvard Business School from 2000 to 2002, where they earned their Master of Business Administration (MBA) with a focus on Business. Prior to that, they studied at The Wharton School from 1991 to 1995, obtaining a Bachelor of Science (B.S.) degree in Finance and Accounting. Simultaneously, they pursued a Bachelor of Arts (B.A.) in International Relations at the University of Pennsylvania, completing their studies in the same period from 1991 to 1995.